中文
EN
News Center
News Center
Viwit Pharmaceuticals obtained the Drug Production License C
Author：
Release Time：
2023-10-30
Congratulations to Viwit Pharmaceuticals that Viwit obtained the Drug Production License C for solid preparations and injections on July 28th, 2023. Meaning, that Viwit’s production lines for solid preparations and injections own the qualification on contracted manufacturing.
Viwit’s solid preparations production line supports the manufacturing of Tablets and Capsules with a capability of about 1,600,000 tablets/day (in 0.2 g and 5 mm).
Viwit’s Injection production line, including small-volume Ampoule and Vial Injections, supports terminal sterile and non-terminal sterile production.
Drug and Medical Device Internet Information Service Filing Number: 沪网药信备字〔2025〕00283号 Internet Information Service Filing Number: 沪ICP备12014533号